Analyst upgrades Nutrien to Overweight, raising price target to $77
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 14 Jan 26
Source: Benzinga
Nutrien Ltd's stock rose by 4.68% during regular trading, reaching a 20-day high.
Morgan Stanley analyst Vincent Sinisi upgraded Nutrien from Equal-Weight to Overweight, increasing the price target from $70 to $77, reflecting improved confidence in the company's profitability. This upgrade comes amid a broader market decline, with the Nasdaq-100 down 0.61% and the S&P 500 down 0.50%.
The upgrade is expected to enhance investor sentiment towards Nutrien, potentially attracting more buyers and supporting further price appreciation.
Analyst Views on NTR
Wall Street analysts forecast NTR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NTR is 66.08 USD with a low forecast of 58.00 USD and a high forecast of 76.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
6 Buy
8 Hold
1 Sell
Moderate Buy
Current: 71.600
Low
58.00
Averages
66.08
High
76.00
Current: 71.600
Low
58.00
Averages
66.08
High
76.00
About NTR
Nutrien Ltd. is a global provider of crop inputs and services. The Company operates a network of production, distribution and ag retail facilities. The Company’s segments include Nutrien Ag Solutions (Retail), Potash, Nitrogen and Phosphate. Its downstream Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and provides agronomic application services and solutions, including the services offered through Nutrien Financial. The Retail segment also manufactures and distributes proprietary products and provides services directly to farmers through a network of retail locations in North America, South America and Australia. Its upstream Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each segment produces and are supported by midstream activities, which include the global sales, freight, transportation and distribution of its products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
